HAP Journal of Public Health and Clinical Medicine
issue front

Padmanabhan Arjun1, Sanjeev Nair2, Veena Babu3, Ashwin S. Nair3, Soumya Gopakumar4, Krishnapillai Vijayakumar3 and Vellappillil Raman Kutty3

First Published 22 Dec 2022. https://doi.org/10.1177/jpm.221135948
Article Information Volume 1, Issue 1 January 2023
Corresponding Author:

Sanjeev Nair, 5A, Omega Paradise, Thekkemadom Road, Thrissur, Kerala 680001, India
Email: drsanjeevnair@gmail.com

1 SP Fort Hospital, Thiruvananthapuram, Kerala, India
2 Government Medical College, Thrissur, Kerala, India
3 Health Action by People, Thiruvananthapuram, Kerala, India
4 Government Medical College, Thiruvananthapuram, Kerala, India

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-Commercial use, reproduction and distribution of the work without further permission provided the original work is attributed.

Abstract

Background: India is initiating measures to address Chronic Obstructive Pulmonary Disease(COPD) and Asthma, major causes of mortality and morbidity, at the primary care level. The efforts are limited by the lack of access to spirometry. Various alternatives are being tried out in resource limited countries.

Methods: A hospital based cross-sectional study was done at two tertiary care hospitals in Trivandrum, South India, in patients with a clinical diagnosis of COPD or Asthma. Spirometry was done by a trained spirometry technician, along with peak-flow recording and a recording on portable mini-spirometer (COPD6 ®). The values obtained by the latter two were compared to those obtained by spirometry.

Results: The study included 360 patients. PEFR showed a positive correlation with both FEV1/FVC as well as FEV1 (R2 of 0.35 and 0.65, respectively). FEV1/FEV6 and FEV1 on COPD6 also correlated positivity with FEV1 and FEV1/FVC on spirometry (R2 of 0.68 and 0.89, respectively). Sensitivity and specificity of PEFR to diagnose obstruction was best at a cut-off of 74% of predicted, as determined by ROC, giving sensitivity of 84.8% and specificity of 85.1%. Sensitivity and specificity of COPD6 to detect obstruction was 75.9% and 95.7%, respectively.

Conclusion: Mini-spirometry (COPD6) and peak-flow measurement may be used as alternatives to spirometry in resource limited settings as in the primary care centers of India for the diagnosis of obstructive airway diseases.

Keywords

Pulmonary disease, chronic obstructive, Asthma, respiratory function tests, prevention and control, Kerala

References
  1. 2022 GOLD Reports. Global Initiative for Chronic Obstructive Lung Disease - GOLD. Accessed February 20, 2022. https://goldcopd.org/2022-gold-reports-2/
  2. 2022 GINA Report, Global Strategy for Asthma Management and Prevention. Accessed May 11, 2022. https://ginasthma.org/wp-content/uploads/2022/05/GINA-Main-Report-2022-FINAL-22-05-03-WMS.pdf
  3. GBD Compare | IHME Viz Hub. Accessed May 11, 2022. http://vizhub.healthdata.org/gbd-compare
  4. GBD India Compare | IHME Viz Hub. Accessed February 20, 2022. http://vizhub.healthdata.org/gbd-compare/india
  5. Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, Sadatsafavi M. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2016;20(1):11-23. doi:10.5588/ijtld.15.0472
  6. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest. 2013;143(5):1395-1406. doi:10.1378/chest.12-1135
  7. Mills A. Health care systems in low- and middle-income countries. N Engl J Med. Accessed May 11, 2022. https://www.nejm.org/doi/full/10.1056/nejmra1110897
  8. Vanjare N, Chhowala S, Madas S, Kodgule R, Gogtay J, Salvi S. Use of spirometry among chest physicians and primary care physicians in India. Npj Prim Care Respir Med. 2016;26(1):1-5. doi:10.1038/npjpcrm.2016.36
  9. Arjun P, Nair S, Jilisha G, et al. Assessing health-seeking behavior among Asthma and COPD patients in urban South India. J Fam Med Prim Care. 2019;8(8):2714-2719. doi:10.4103/jfmpc.jfmpc_485_19
  10. Operational Guidelines of NPCDCS (Revised - 2013-17)_1.pdf. Accessed May 11, 2022. https://dghs.gov.in/WriteReadData/userfiles/file/Publication/Operational%20Guidelines%20of%20NPCDCS%20(Revised%20-%202013-17)_1.pdf
  11. Directorate General of Health Services Ministry of Health & Family welfare Government of India. Medical Officer’s Manual for Prevention and Management of Chronic Obstructive Pulmonary Disease & Asthma. 2021.
  12. Kodgule RR, Singh V, Dhar R, et al. Reference values for peak expiratory flow in Indian adult population using a European Union scale peak flow meter. J Postgrad Med. 2014;60(2):123. doi:10.4103/0022-3859.132311
  13. easyROC: a web-tool for ROC curve analysis (ver. 1.3.1). Accessed May 12, 2022. http://www.biosoft.hacettepe.edu.tr/easyROC
  14. Pan Z, Dickens AP, Chi C, et al. Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well group. BMJ Open. 2021;11(9):e051811. doi:10.1136/bmjopen-2021-051811
  15. Thorat YT, Salvi SS, Kodgule RR. Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice: a cross-sectional study. NPJ Prim Care Respir Med. 2017;27(1):32. doi:10.1038/s41533-017-0036-8
  16. Gopakumar S, Valamparampil MJ, Manu MS, et al. The first state-level public health program for obstructive airway disease in India: An early field-level evaluation. J Fam Med Prim Care. 2020;9(9):4998-5003. doi:10.4103/jfmpc.jfmpc_216_20

 

issue front

Order a Print Copy